Egyptian Price Reform Ruling Soon; What's Next For MNC Drug Makers?
This article was originally published in PharmAsia News
Executive Summary
In less than one month, the Supreme Administrative Court of Egypt will resume proceedings on Decree 373, the new drug pricing scheme proposed by the Ministry of Health to simplify the current system and make prices more predictable. The proposals have encountered balking from both drug makers and consumer advocacy groups, and now healthcare analysts think the reforms may need major reworking